Trends & Business

Kappa Bioscience (Oslo, Norway) has appointed John E. Repine, MD as the newest member of its “Blue Ribbon” Scientific and Medical Advisory Board.

The new Strand Defender conditioner protects hair strands that have already grown out of the scalp.

The elderberry portfolio includes extracts standardized to 6% and 10% anthocyanins in both standard and organic grades.

The new Laboratory Guidance Document provides an evaluation of 46 analytical methods and their suitability to authenticate Boswellia serrata oleogum resin and its extracts.

It’s no wonder that the botanical industry has fixated on fears of adulteration in these challenging times.

The study, which the company expects to publish later this year, found that enXtra from OmniActive Health Technology quickly increased subjects' mental alertness that sustained for five hours.

ChenlandNutritionals’ ingredient CuminUP60 is now self-affirmed GRAS (generally recognized as safe) with assistance from GRAS Associates, a fully owned subsidiary of Nutrasource

Under this new partnership, ADM will process and commercialize a portfolio of proprietary ingredients made up from Benson Hill Ultra-High Protein (UHP) soybeans.

A bipartisan group of members from the House Energy and Commerce Committee has sent a letter to Speaker Nancy Pelosi and Minority Leader Kevin McCarthy requesting that the use fee reauthorization agreement not include the dietary supplement provision found in the FDA Safety and Landmark Advancements (FDASLA) Act.

The 45,000-sq-ft facility is located in Mount Vernon, MO.

How do companies thrive when there are too many jobs and not enough people to fill them?

Bill Chioffi previously served as vice president of global sourcing and sustainability at Gaia Herbs.

Clasado Biosciences is expanding distribution of its GOS prebiotic ingredient in Asia Pacific.

In an August 8 open letter to the dietary supplements industry about the FDA Safety & Landmark Advancements Act (FDASLA) and mandatory product listing proposals, the Council for Responsible Nutrition’s President and CEO Steve Mister reports that “negotiations for dietary supplement product listing continue with progress made each day toward getting a final bill that CRN can support.”

TerraCycle’s innovative waste-management capabilities enable products and packages like dirty diapers and cigarette butts that would otherwise end up in a landfill to be recycled.

The two new products are designed to support intensity and endurance during exercise.

With elderberry’s fortunes rising along with the research, can we expect its good luck to continue?

Gummy supplements producer TopGum received designation as a USDA-certified organic manufacturer from international certifier Organic Certifier.

Using this method, the company can produce protein isolates, natural colors, flavor enhancers, gluten substitutes, and other useful compounds.

Maolac says it will use the funds to build a facility with small-scale production capabilities.

Prebiotic companies are taking delivery forms to a whole new level.

FruitSmart’s fiber ingredients are produced from the leftover materials from the company’s FruitSmart cold-press fruit-pressing process.

In early-stage canola field trials, the platform significantly increased seed weight per hectare for canola crops.

Anthocyanins hold value beyond their coloring effects. They can impart many functional properties in functional and nutritional foods, too.

Together, Agravitae and TKO Farms have developed a proprietary process to freeze dry the vine-ripened fruit to preserve its nutritional qualities. Armed with this new technology, they have also developed a range of products that are making their way into the U.S. market.

AHPA’s chief science officer, Holly E. Johnson, PhD, sat down with Nutritional Outlook to talk about what AHPA hopes to achieve with this year’s Botanical Congress program and its focus on Planet Earth. The event takes place virtually on August 16-17.

Kelai Pharmaceutical’s goal is to identify drug candidates in botanical plants to develop pharmaceuticals.

In addition to their ongoing goal of conducting in-depth consumer research, the two companies are launching the second phase of a joint clinical trial known as “Project Happy.”